Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer [Phase 3]
Phase 3 trial on using circulating tumor cell counts to optimize systemic therapy for metastatic prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer [NA]
Clinical trial update on MRI-guided SBRT with simultaneous integrated boost for prostate cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy [Phase 2]
Phase 2 trial update of TRC105 in combination with abiraterone or enzalutamide in prostate cancer; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of enzalutamide and cabazitaxel for metastatic castration-resistant prostate cancer; results were…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients [Phase 2]
Phase 2 trial evaluating Gallium-68-HBED-CC-PSMA imaging in prostate cancer completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2020-12-22Clinical Trial Update: Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines [Phase 1]
Phase 1 trial evaluating a multi-targeted recombinant vaccine (Ad5 PSA/MUC1/Brachyury) for castration-resistant prostate cancer; completed w…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer [Phase 2]
Phase 2 trial evaluating safety, tolerability, and efficacy of Liproca Depot Injection in patients with Prostate Cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model
Clinical trial update describing a two-stage statistical model to model clinical failure in prostate cancer patients; results completed and …
-
FDA approval · 2020-12-18FDA Approved: ORGOVYX — Original Application (Sumitomo Pharma America, Inc.)
The FDA approved ORGOVYX (relugolix) under an original NDA submitted by Sumitomo Pharma America, marking the approval of a new treatment opt…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer [NA]
A completed clinical trial assessing hypofractionated accelerated radiotherapy for low-risk localized prostate cancer with results posted in…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer [Phase 2]
A multi-center Phase 2 randomized trial is investigating irreversible electroporation (IRE) for ablation of localized prostate cancer.
-
FDA approval · 2020-12-14FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Abiraterone Acetate from Mylan Pharmaceuticals Inc., supporting the availability of a generi…
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse [NA]
A completed clinical trial comparing ultrasound-based planning to CT-based planning for high-dose-rate prostate brachytherapy, with results …
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients [Phase 2, Phase 3]
Phase 2/3 trial of Gallium-68 PSMA-11 PET imaging in intermediate to high-risk prostate cancer patients undergoing preprostatectomy has comp…
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients [Phase 4]
Phase 4 study of Eligard (leuprolide acetate) in hormone-dependent prostate cancer completed and results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for abiraterone in metastatic castration-resistant prostate cancer, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. [Phase 4]
Phase 4 trial comparing immediate 9-month adjuvant hormone therapy with triporelin versus active surveillance after radical prostatectomy in…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases [Phase 4]
Phase 4 trial comparing 4-weekly versus 12-weekly administration of bone-targeted agents in patients with bone metastases.
-
FDA approval · 2020-12-01FDA Approved: GALLIUM GA-68 PSMA-11 — Original Application (UCSF Radiopharmaceutical Facility)
FDA approved Gallium-68 PSMA-11 (gallium-68 gozetotide) for PET imaging to detect PSMA-expressing lesions in adult men with suspected prosta…
-
FDA approval · 2020-12-01FDA Approved: GALLIUM GA-68 PSMA-11 — Original Application (UCLA Biomedical Cyclotron)
FDA approved Gallium-68 PSMA-11 (Gallium-68 gozetotide) for PET imaging of PSMA-expressing lesions in men with suspected metastatic prostate…
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Prostate Adenocarcinoma TransCutaneous Hormones [Phase 3]
A Phase 3 clinical trial update for TransCutaneous Hormones in prostate adenocarcinoma, with listed conditions including anemia, cardiovascu…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer [Phase 2]
Phase II trial comparing PAP Plus GM-CSF versus GM-CSF alone in non-metastatic prostate cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy [Phase 2]
Phase 2 trial update for enzastaurin in prostate cancer patients who have undergone hormonal therapy and chemotherapy has completed with res…
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer [Phase 1, Phase 2]
Clinical trial update for stereoTactic Ablative Adaptive Radiotherapy treatments in localized prostate cancer (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer [Phase 2]
Phase 2 study of Aplidin (Plitidepsin) in advanced prostate cancer was terminated, with results posted in 2020.